/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2025-09-23-20-27-02-812-68d30296602d699e7a35147a.png)
Investing in high-risk jurisdictions—regions affected by conflict, political instability, or weak governance—can offer unique...
A Fresh Take
Insights on US legal developments
/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2024-10-15-19-53-27-360-670ec837dd71ccaa0996a993.png)
On September 17, 2025, the U.S. Securities and Exchange Commission took a significant step to reverse course on a decades-old policy...
The U.S. federal government appears poised for a partial shutdown, which would occur at 12:01am October 1, 2025. Investors should note...
Multi-national companies doing business in high-risk jurisdictions need to put a date on their calendar: September 28. Why? That is the...
The past nine months have seen significant changes across the antitrust landscape, with a new administration in the US, new leadership of...
Introduction Last month, the SEC settled an Enforcement action, TZP Associates, LLC, IA Rel. No 6908 (Aug. 15, 2025), that alleged an...
For sophisticated litigants, U.S.-style discovery isn’t just for domestic disputes. Thanks to 28 U.S.C. § 1782, parties involved in...
Why do companies venture into the world’s toughest markets? For some companies, entry is not a choice but a consequence of shifting...
Businesses today increasingly operate in regions where conflict and violence undermine traditional ways of doing business. From surges in...
On September 10, 2025 the Department of Defense (DoD) issued its final rule (Rule) amending the Defense Federal Acquisition Regulation...
Significant Chinese investment in its biotechnology industry has resulted in a shift in the biopharma licensing market over the last five...
The BIOSECURE Act, first introduced in Congress last year, has now been reintroduced for inclusion in Senate’s draft of the annual...